Two New Kindreds with Germline CEBPA Mutations and Acute Myeloid Leukemia (AML)

被引:0
|
作者
Stuckert, A. [1 ,2 ]
Scollon, S. [1 ,2 ]
Sen, S. [1 ,2 ]
Yassine, K. [1 ,2 ]
Doherty, E. [1 ,2 ]
Dreyer, Z. [1 ,2 ]
Rau, R. [1 ,2 ]
机构
[1] Texas Childrens Hosp, Houston, TX 77030 USA
[2] Baylor Coll Med, Pediat Hematol Oncol, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PV0084
引用
收藏
页码:S194 / S194
页数:1
相关论文
共 50 条
  • [31] Hereditary acute myeloid leukemia associated with C-terminal CEBPA germline variants
    Harrigan, Amye M.
    Trottier, Amy M.
    FAMILIAL CANCER, 2023, 22 (03) : 331 - 339
  • [32] Classification of CEBPA mutated acute myeloid leukemia by GATA2 mutations
    Marceau-Renaut, Alice
    Guihard, Soizic
    Castaigne, Sylvie
    Dombret, Herve
    Preudhomme, Claude
    Cheok, Meyling
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (05) : E93 - E94
  • [33] Impact of secondary-type mutations in acute myeloid leukemia with CEBPA mutation
    Zhao, Davidson
    Rumina, Musani
    Zarif, Mojgan
    Wei, Cuihong
    Chang, Hong
    EJHAEM, 2024,
  • [34] Novel Mutations in CEBPA in Korean Patients with Acute Myeloid Leukemia with a Normal Karyotype
    Kim, Sollip
    Kim, Dong-Hwan
    Jang, Jun-Ho
    Jung, Chul-Won
    Jang, Mi-Ae
    Ki, Chang-Seok
    Kim, Jong-Won
    Kim, Sun-Hee
    Kim, Hee-Jin
    ANNALS OF LABORATORY MEDICINE, 2012, 32 (02) : 153 - 157
  • [35] CEBPA gene mutations in Egyptian acute myeloid leukemia patients: impact on prognosis
    Awad, Mohamed M.
    Aladle, Doaa A.
    Abousamra, Nashwa K.
    Elghannam, Doaa M.
    Fawzy, Iman M.
    HEMATOLOGY, 2013, 18 (02) : 61 - 68
  • [36] RUNX1 Mutations Reduce the Expression of CEBPA in Acute Myeloid Leukemia
    Grossmann, Vera
    Kohlmann, Alexander
    Dicker, Frank
    Butschalowski, Katrin
    Kern, Wolfgang
    Schnittger, Susanne
    Haferlach, Torsten
    Haferlach, Claudia
    BLOOD, 2011, 118 (21) : 1040 - 1040
  • [37] FRAGMENT LENGTH ANALYSIS SCREENING FOR CEBPA MUTATIONS DETECTION IN ACUTE MYELOID LEUKEMIA
    Fuster, O.
    Barragan, E.
    Bolufer, P.
    Cervera, J.
    Such, E.
    Montesinos, P.
    Sanz, M. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 18 - 18
  • [38] Functional cooperation of CEBPA and TET2 mutations in Acute Myeloid Leukemia
    Heyes, E.
    Schmidt, L.
    Eder, T.
    Volpe, G.
    Chatziathanasiou, K.
    Schmidt, C.
    Frampton, J.
    Grebien, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 40 - 40
  • [39] CLINICAL IMPACT OF TET2 MUTATIONS IN ACUTE MYELOID LEUKEMIA PATIENTS HARBORING CEBPA MUTATIONS: A STUDY OF THE AML STUDY GROUP (AMLSG)
    Theis, F.
    Corbacioglu, A.
    Gaidzik, V. I.
    Paschka, P.
    Weber, D.
    Bullinger, L.
    Schlegelberger, B.
    Goehring, G.
    Koehne, C. -H.
    Kraemer, D.
    Germing, U.
    Brossart, P.
    Horst, H. -A.
    Haase, D.
    Goetze, K.
    Ringhoffer, M.
    Fiedler, W.
    Nachbaur, D.
    Kindler, T.
    Held, G.
    Luebert, M.
    Wattad, M.
    Salih, H. R.
    Krauter, J.
    Heuser, M.
    Thol, F.
    Ganser, A.
    Doehner, H.
    Schlenk, R. F.
    Doehner, K.
    HAEMATOLOGICA, 2017, 102 : 203 - 204
  • [40] Clinical Assay Design for Detection of CEBPA Mutations in Patients with Acute Myeloid Leukemia
    Deucher, A.
    Chiang, T.
    Seo, K.
    Arber, D. A.
    Zehnder, J.
    Schrijver, I.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 627 - 627